Evidence map›Paper›PMID 30678040›Full record

ArticleProteomes2019

Sex-Specific Proteomic Changes Induced by Genetic Deletion of Fibroblast Growth Factor 14 (FGF14), a Regulator of Neuronal Ion Channels.

Mark L Sowers, Jessica Di Re, Paul A Wadsworth, Alexander S Shavkunov, Cheryl Lichti, Kangling Zhang, Fernanda Laezza

Open access · goldAbstract read
In one paragraph

Article in Proteomes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Paternal epigenetic inheritance increases susceptibility to methamphetamine taking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mark L SowersUTMB MD/PhD Combined Degree Program, University of Texas Medical Branch, Galveston, TX 77555, USA. mlsowers@utmb.edu.
Jessica Di ReDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA. jedire@utmb.edu.
Paul A WadsworthUTMB MD/PhD Combined Degree Program, University of Texas Medical Branch, Galveston, TX 77555, USA. pawadswo@utmb.edu.
Alexander S ShavkunovDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA. asshavku@utmb.edu.
Cheryl LichtiDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA. clichti@wustl.edu.
Kangling ZhangDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA. kazhang@utmb.edu.
Fernanda LaezzaDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA. felaezza@utmb.edu.
The University of Texas Medical Branch at Galveston · US

Funding

Retinoic acid signaling: a novel factor for addiction-related behaviorR01DA047102 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GREEN, THOMAS ARTHUR, LAEZZA, FERNANDA · 2018 to 2022
$2.2M
Validation of FGF14 as a New Molecular Target of GSK3R01MH095995 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA · 2012 to 2016
$1.9M
Discovery of Chemical Probes for Psychiatric Disorders and AddictionR01MH111107 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA, ZHOU, JIA · 2016 to 2018
$1.6M
Oxidation of 5-methylcytosine: DNA damage and epigenetic reprogrammingR01CA184097 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SOWERS, LAWRENCE C, ZHANG, KANGLING · 2014 to 2018
$1.6M
Clinical and Behavioral Science Training in Aging and Health DisparitiesT32AG051131 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MARKIDES, KYRIAKOS S · 2015 to 2019
$436k
NIDA NIH HHS R01 DA047102NIH HHS R01CA184097NIH HHS R01DA047102NIH HHS R01MH095995NIH HHS R01MH111107NIH HHS T32 AG051131NIMH NIH HHS R01 MH095995
6 · The paper itself

Abstract

Fibroblast growth factor 14 (FGF14) is a member of the intracellular FGFs, which is a group of proteins involved in neuronal ion channel regulation and synaptic transmission. We previously demonstrated that male

Indexed as

Alzheimer’s Diseaseautismbioinformaticscognitive impairmentexcitatory/inhibitory toneFGF14mass spectroscopyschizophreniasex-specific differencessynaptic plasticityvoltage gated channels

Identifiers

PMID30678040
PMCPMC6473632
OpenAlexW2911079439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.